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Abstract—Fetal growth restriction and preeclampsia are both conditions of placental etiology and associated to increased
risk for the long-term development of cardiovascular disease in the mother. At presentation, preeclampsia is associated
with maternal global diastolic dysfunction, which is determined, at least in part, by increased afterload and myocardial
stiffness. The aim of this study is to test the hypothesis that women with normotensive fetal growth-restricted
pregnancies also exhibit global diastolic dysfunction. This was a prospective case-control study conducted over a 3-year
period involving 29 preterm fetal growth-restricted pregnancies, 25 preeclamptic with fetal growth restriction pregnancies, and
58 matched control pregnancies. Women were assessed by conventional echocardiography and tissue Doppler imaging
at diagnosis of the complication and followed-up at 12 weeks postpartum. Fetal growth-restricted pregnancies are
characterized by a lower cardiac index and higher total vascular resistance index than expected for gestation. Compared
with controls, fetal growth-restricted pregnancy was associated with significantly increased prevalence (P0.001) of
asymptomatic left ventricular diastolic dysfunction (28% versus 4%) and widespread impaired myocardial relaxation
(59% versus 21%). Unlike preeclampsia, cardiac geometry and intrinsic myocardial contractility were preserved in fetal
growth-restricted pregnancy. Fetal growth-restricted pregnancies are characterized by a low output, high resistance
circulatory state, as well as a higher prevalence of asymptomatic global diastolic dysfunction and poor cardiac reserve.
These findings may explain the increased long-term cardiovascular risk in these women who have had fetal
growth-restricted pregnancies. Further studies are needed to clarify the postnatal natural history of cardiac dysfunction
in these women. (Hypertension. 2012;60:437-443.) ● Online Data Supplement
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Fetal growth restriction (FGR) and preeclampsia (PE) areboth conditions of placental etiology with shared charac-
teristics of maternal vascular endothelial activation, oxidative
stress, and upregulation of the inflammatory state.1,2 FGR and
PE are both also associated with increased risk for the long-term
development of metabolic syndrome and cardiovascular disease
in the mother.3–9 Acute PE is associated with cardiac remod-
eling, impaired myocardial relaxation and global left ventric-
ular (LV) diastolic chamber dysfunction.10,11 Furthermore, it
is evident that the cardiovascular implications of PE do not
cease with the birth of the infant, with a significant proportion
of women demonstrating asymptomatic LV diastolic chamber
dysfunction and essential hypertension for within 2 years of
delivery.11,12 Despite these cardiovascular findings in PE,
previous studies of maternal cardiac function in FGR preg-
nancy failed to identify a clear pattern of myocardial impair-
ment or chamber dysfunction.13–16 This is possibly due to the
inadequacy of the load-dependent indices used and the
interpretation of diastolic measures in isolation, disregarding
the interdependency of cardiac events. The aim of this study
was to test the hypothesis that women with normotensive
FGR pregnancies also exhibit cardiac remodeling and myo-
cardial and ventricular dysfunction, as seen in PE pregnancies
using established diagnostic algorithms integrating conven-
tional echocardiographic and tissue Doppler indices.
Methods
This was a prospective case-control study carried out over a 3-year
period from February 2008. All of the women with singleton
pregnancy and normotensive FGR attributed to placental insuffi-
ciency severe enough to require iatrogenic preterm (before 37 weeks)
delivery were recruited consecutively as cases, after informed
consent and with local institutional review committee approval. Only
women without comorbidities, who were nonsmokers, not on med-
ication, or in labor were asked to take part in the study. Normoten-
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sive FGR because of placental insufficiency was defined as an
abdominal circumference 10th centile, umbilical artery pulsatility
index above the 95th centile, need of preterm iatrogenic delivery for
fetal compromise, absence of known chromosomal/structural fetal
abnormality, and no concurrent maternal illness. All of the FGR
pregnancies underwent a full assessment of fetal biometry, fetal
Doppler, biophysical profile, and computerized cardiotocography at
study entry and 3 times weekly until delivery. Women who
developed hypertension or other medical complications during preg-
nancy or postpartum were subsequently excluded. For each FGR
pregnancy, 2 normotensive, healthy, nonsmoking controls matched
for maternal age, gestational age, and ethnicity were recruited from
the routine antenatal clinic. Women with adverse pregnancy outcome
were retrospectively excluded from being controls. Women with
preterm PE with FGR recruited to another study during the same
period were matched for gestational age and used as a secondary
control group.11 Maternal assessment included a medical and family
history, measurement of anthropometric indices, blood pressure
profile, conventional echocardiography, tissue Doppler and strain
rate assessment, and 12-lead ECG. Twelve weeks postpartum,
women underwent physical examination and repeat blood pressure
profile. Maternal blood pressure was measured manually from the
brachial artery using a mercury sphygmomanometer according to the
guidelines of the National High Blood Pressure Education Program
Working Group on High Blood Pressure in Pregnancy.12
Echocardiography
All of the subjects were studied by standard 2D and Doppler
transthoracic echocardiography at rest, as described previously.10 In
brief, patients were studied in the left lateral decubitus position and
data acquired at end expiration from standard parasternal/apical
views using a GE Vivid 9 scanner. For each acquisition, 3 cardiac
cycles of noncompressed data were stored in cine-loop format and
analyzed without blinding offline by one investigator (K.M.). Tissue
Doppler, strain, and strain rate indices are given as absolute values.
Diastolic chamber function, chamber filling pressures, and geometry
were assessed and graded using standard diagnostic algorithms with
the recommended adjustments reflecting the concomitant systolic
function, age, and pregnancy.10,17 Ejection fraction was evaluated by
biplane Simpson method, and left ventricular LV global radial systolic
dysfunction was defined as Ejection fraction 55%.18 Systolic
chamber dysfunction was defined as average peak systolic velocity at
the level of the left and septal sites of mitral valve annulus (Av S1)
index 2 SDs below the expected mean for age. The severity of LV
dysfunction and remodeling was graded accordingly to the European
Association and American Society of Echocardiography guide-
lines.17,18 Impaired myocardial contractility was diagnosed if the
peak systolic strain rate indices were 2 SDs below the expected mean
for age. Impaired myocardial relaxation was defined as early:late
strain rate ratio 1. All of the conventional echocardiographic
indices were adjusted for body surface area, and all of the tissue
Doppler velocity indices were adjusted for the end-diastolic LV
long-axis length. Please also see the extended methodology in the
online-only Data Supplement.
Statistical Analysis
Data were analyzed using SPSS 15 software (SPSS Inc, Chicago,
IL). Variables were compared using Mann-Whitney U or 2 tests, as
appropriate. Paired-group comparisons were only undertaken if
Kruskal-Wallis testing indicated significant differences. Stepwise
multiple regression analysis was used to assess the influence of
cardiac parameters, demographic variables (ethnicity, maternal age,
and body mass index), and pregnancy characteristics on indices of
cardiac function and remodeling. A required sample size of 22 in
each group was calculated to observe a 20% difference in average
E/E1 ratio between cases and controls with 85% power and a 5%
type 1 risk.10 The reproducibility and repeatability of both conven-
tional and tissue Doppler indices were assessed previously and found
to be very good.10
Results
A total of 29 normotensive women with severe preterm FGR,
25 women with preterm PE with FGR, and 58 women with
normal pregnancies were included in the study. Cases and
controls did not differ significantly for maternal age, ethnic-
ity, and gestational age at assessment, but FGR cases had
significantly higher body mass index than controls (Table 1).
As expected, PE women presented with abnormal liver and
kidney function, whereas abnormal hematology was present
in both pregnancy complications (please see Table S1 in the
online-only Data Supplement). Both PE and normotensive
FGR pregnancies had a high prevalence of adverse fetal and
neonatal outcomes (41% and 36%, respectively, versus 0% of
controls; Table 1).
Hemodynamic and Remodeling Indices
FGR women had significantly higher total vascular resistance
index and mean arterial pressure and lower cardiac index and
heart rate compared with controls. There was no difference in
stroke volume, heart remodeling indices, wall stress, and
cardiac work indices between cases and controls (Table 2 and
Figure 1; see Table S2).
Diastolic Function
Women with normotensive FGR had a significantly higher
prevalence of severe impaired myocardial relaxation (59%)
than controls (21%; P0.0001; Tables 3 and 4; please see
Table S3). Eight women with FGR (27.6%; 5 grade I, 2 grade
Ia, and 1 grade II) exhibited overt diastolic chamber dysfunc-
tion compared with 2 (4%; 2 grade I) in the control group
(P0.009; Tables 3 and 4 and Figure 2; please see the
grading system of diastolic dysfunction in the online-only
Data Supplement).
Systolic Function
Pulsed tissue Doppler peak systolic velocity indices at lateral
and septal mitral annulus sites were significantly reduced in
FGR cases versus controls irrespective of correction for LV
end-diastolic long-axis length (Table 2). Peak systolic strain,
strain rate, and LV radial systolic function indices were not
significantly different between the 2 study groups (Table 2;
see Tables S4 and S5).
Cardiovascular Changes in PE With FGR
Women with PE presented with higher total vascular resis-
tance index and mean arterial pressure and lower cardiac
index and stroke volume index than controls. LV geometry
was significantly altered in PE with marked concentric
hypertrophy with overt systolic and diastolic chamber dys-
function (Tables 2–4 and Figures 1 and 2). Global diastolic
dysfunction was seen in 52% of women with PE, and half of
them also presented increased left chamber filling pressures
(Tables 3 and 4). PE women also exhibited extensive im-
paired myocardial relaxation and depressed myocardial con-
tractility, as demonstrated by the strain rate indices at multi-
ple cardiac sites (Tables 3 and 4 and Figures 1 and 2).
FGR Versus PE
Women with normotensive FGR demonstrated similar changes
in cardiac ventricular function to women with preterm PE with
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FGR. Changes in indices and impairment of cardiac function
were always significantly more frequent and more severe in
PE with FGR compared with normotensive FGR alone
(Tables 2–4 and Figures 1 and 2). In contrast to PE with
FGR, women with normotensive FGR had no evidence of LV
altered geometry or impaired myocardial contractility com-
pared with controls (Table 4 and Figure 2).
Interdependency of Indices
Multiple regression analysis showed that diastolic function
indices were independently associated with mean arterial
pressure and body mass index (please see Table S6). The
other demographic and pregnancy characteristics did not
independently contribute to the echocardiographic findings.
Discussion
The findings of this study demonstrate that the maternal
cardiovascular responses in FGR are similar to those seen in
PE, albeit less severe. Two thirds of women with FGR
pregnancies showed evidence of poorer diastolic reserve, as
demonstrated by impaired myocardial relaxation, and a third
had overt diastolic chamber dysfunction despite a normal
ejection fraction. These findings are in keeping with the
common placental etiology of both FGR and PE pregnancies
and have clinical relevance in view of the high long-term risk
of overt heart failure in patients with impaired left ventricle
diastolic function. The cardiovascular findings were either
more prevalent or more severe in women with PE pregnan-
cies, with features of impaired myocardial contractility and
systolic chamber dysfunction. Although previous studies
assessed cardiac function in FGR pregnancies, they failed to
demonstrate definitive or consistent findings. The most likely
reason for this discrepancy is that previous studies invariably
evaluated cardiac indices in isolation, where no individual
echo index is capable of diagnosing or grading diastolic
dysfunction, a distinct entity from systolic dysfunction or
failure.12,17 Moreover, previous studies did not take into
account the strong age-dependency of diastolic indices and
used only conventional echocardiography. Although the gold
standard for assessing diastolic function remains the invasive
acquired pressure-volume relationship, the integration of
conventional echo indices with tissue Doppler and strain rate
indices applying age-adjusted cutoff allowed us to accurately
diagnose and grade diastolic function in these young women.
In contrast, the preservation of myocardial contractility and
radial systolic function despite impairment of longitudinal
systolic function in women with FGR pregnancies were
supported by those of previous studies.13–15
Table 1. Demographic and Pregnancy Characteristics of Cases With Normotensive Preterm FGR, PE With FGR, and Controls
Parameter
Controls
(n58)
FGR
(n29)
PE With
FGR (n25)
FGR vs
Controls
PE With FGR
vs Controls
FGR
vs PE
Demographic characteristics
Maternal age, y 31 (27–35) 30 (27–34) 32 (25–35) 0.9* 0.9 0.06
Nulliparous 28 (48) 14 (48) 18 (72) 0.82 0.08 0.2
White 34 (59) 17 (59) 9 (36) 0.82* 0.1 0.2
Afro-Caribbean 6 (10) 3 (10) 7 (28) 0.71* 0.1 0.2
Asian 18 (31) 9 (31) 11 (44) 0.81* 0.4 0.5
Prepregnancy BMI, kg/m2 22.5 (21.2–25.5) 28.1 (23.2–32.4) 26.3 (21.6–33.1) 0.037 0.8 0.24
Prepregnancy BMI 30, kg/m2 3 (6) 7 (32) 3 (12) 0.024 0.5 0.4
Prepregnancy BSA, m2 1.44 (1.32–1.58) 1.42 (1.2–1.9) 1.54 (1.45–1.59) 0.3 0.2 0.34
Maternal height, m 1.65 (1.60–1.70) 1.63 (1.55–1.68) 1.68 (1.60–1.71) 0.2 0.5 0.09
Pregnancy characteristics
SBP at 12 wk (mm Hg) 110 (100–115) 106 (100–110) 120 (110–130) 0.7 0.001 0.001
DBP at 12 wk (mm Hg) 67 (60–71) 65 (60–72) 60 (60–70) 0.5 0.5 0.5
Second trimester UtA mean PI 0.70 (0.67–1.05) 1.21 (1.52–1.97) 1.28 (1.50–2.1) 0.0001 0.0001 0.6
BMI at assessment (kg/m2) 26.5 (22.1–30.0) 30.1 (25.8–33.1) 27.2 (24–38.2) 0.028 0.2 0.07
BSA at assessment (m2) 1.62 (1.54–1.76) 1.57 (1.34–2.35) 1.61 (1.54–1.82) 0.69 0.1 0.7
Gestational age at assessment (wks) 31 (26–35) 30 (26.5–32) 30 (26–33) 0.6* 0.7 0.3
Pregnancy outcome
Gestational age at delivery (wks) 40.5 (39–41.7) 32 (29.2–34.1) 33 (29.5–34.5) 0.0001† 0.0001 0.9
Birth weight centiles‡ (%) 45.2 (24–57.2) 1.52 (0.34–3.58) 2.5 (2.13–6.7) 0.0001† 0.0001 0.0001
Adverse fetal or neonatal outcomes§ 0 12 (41) 9 (36) 0.0001 0.0001 0.6
Values are given as median (interquartile range) or No. of subjects (percentage). FGR indicates fetal growth restriction; BMI, body mass index; BSA, body surface
area; SBP, systolic blood pressure; DBP, diastolic blood pressure; UtA, uterine artery; PE, preeclampsia; PI, pulsatility index.
*Data are not significant as per method.
†Data are significant as per method.
§Adverse fetal or neonatal outcome is defined as the presence of at least one of the following: respiratory distress, broncho-pulmonary dysplasia, need of
mechanical ventilation, necrotizing enterocolitis, intracerebral hemorrhage, periventricular leucomalacia, sepsis, or perinatal death.
‡Birth weight centiles were determined using the curve references from Gardosi et al.35
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Diastolic dysfunction is known to occur variably as a
consequence of increased LV stiffness, increased afterload,
and/or derangements of the myocardial milieu.16 Multiple
regression analysis in our cohort of normotensive FGR
pregnancies suggested that global diastolic dysfunction was
related to both a higher afterload, as demonstrated by the
increased mean arterial pressure and maternal increased body
mass index. Several mechanisms evident in high body mass
index individuals could influence maternal cardiac function,
including inflammation, endothelial dysfunction, thrombotic
tendency, and LV hypertrophy attributed to an increased
blood volume.19 In particular, the metabolic effects of obesity
resulting in dyslipidemia and insulin resistance seem to be the
most likely mediators of changes in maternal cardiac function
Table 2. Hemodynamic and Left Ventricular Geometric and Systolic Functional Parameters of Normotensive Preterm FGR, PE With
FGR, and Controls
Parameters
Controls
(n58)
FGR
(n29)
PE With
FGR (n25)
FGR vs
Controls
PE With FGR
vs Controls
FGR
vs PE
Hemodynamic indices
HR, bpm 77 (75–91) 67 (62–74) 78 (70–90) 0.0001 0.08 0.004
SBP at assessment, mm Hg 110 (93–120) 120 (110–130) 150 (150–160) 0.006 0.0001 0.0001
DBP at assessment, mm Hg 70 (60–80) 78 (70–80) 100 (95–105) 0.037 0.0001 0.0001
MAP, mm Hg 80 (73–88) 94 (87–98) 118 (115–120) 0.0001 0.0001 0.0001
CI, L/min/m2 3.48 (3.09–3.90) 2.73 (2.55–3.26) 2.58 (2.16–2.70) 0.0001 0.0001 0.013
SVI, mL/m2 40 (38–46) 42 (35–48) 35 (26–46) 0.6 0.001 0.031
TVRI, (dynes1cm5)m2 1857 (1553–2005) 2456 (2197–2894) 3622 (3205–4391) 0.0001 0.0001 0.0001
Hematocrit, % 33 (31.5–35.0) 36 (35.8–37.3) 0.36 (34.7–37.5) 0.001 0.001 0.9
Hemoglobin, g/dL 10.6 (10.5–11.8) 12.3 (11.5–12.7) 11.9 (11.2–12.6) 0.006 0.008 0.6
Geometric indices
LVMI, g/m2 68 (51–79) 69 (61–80) 75 (58–112) 0.3 0.01 0.03
RWT 0.31 (0.29–0.35) 0.35 (0.30–0.37) 0.44 (0.40–0.53) 0.7 0.0001 0.0001
Longitudinal systolic function,
mitral annulus sampling
S1/LAX (1/s) septal side 1.1 (0.95–1.3) 0.89 (0.84–1.1) 0.90 (0.73–1.2) 0.03 0.04 0.09
S1/LAX (1/s) lateral side 1.3 (1.0–1.9) 0.90 (0.81–1.1) 0.93 (0.75–1.2) 0.01 0.01 0.5
Values are given as median (interquartile) or No. (percentage). HR indicates heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean
arterial pressure; CI, cardiac index; SVI, stroke volume index; TVRI, total vascular resistance index; LVM, left ventricular mass; LVMI, left ventricular mass index
normalized for body surface area (BSA); RWT, relative wall thickness; S1, pulsed wave Doppler peak systolic velocity; LV, left ventricle; LAX, end-diastolic LV long
axis length; long-axis shortening, mitral ring displacement normalized for LAX (expressed in mm); S1/LAX, pulsed wave Doppler peak systolic velocity normalized for
LAX (expressed in cm); FGR, fetal growth restriction; PE, preeclampsia.
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Figure 1. Hemodynamic status in pregnant controls (1), normotensive preterm fetal growth restriction (NT FGR; 2), and preterm pre-
eclampsia (PE) associated with FGR (3). A, Total vascular resistance index (TVRI): total vascular resistance index expressed in
(dynes1cm5)m2. B, CI indicates cardiac index in Lmin1m2. (*P0.01 vs pregnant control; †P0.01 vs pregnant control
and NT FGR).
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through changes in the composition and material properties of
the myocardium.19–24 This assertion is indirectly supported
by a recent study demonstrating that 20% of women who
previously had a normotensive FGR pregnancy had features
of metabolic syndrome.25 The endothelial dysfunction is
another known mechanism of diastolic impairment26 and
could also play a role in the diastolic abnormalities seen in
normotensive FGR, as well as PE pregnancies. This is
indirectly supported by studies demonstrating signs of endo-
thelial dysfunction in normotensive FGR pregnancies, such as
abnormal endothelial-dependent microvascular dilatation27
and increased intercellular adhesion molecule and vascular
cell adhesion molecule.28
During normal pregnancy, the cardiac output and plasma
volume both expand by 50%, whereas the increase in red
cell mass is 30%, resulting in a dilutional “fall” in hemo-
globin concentration.29,30 This low-resistance, high-volume,
hyperdynamic and hemodiluted pregnant state would appear
Table 3. Diastolic Function Indices in Normotensive Preterm FGR, PE With FGR, and Controls
Parameter
Controls
(n58)
FGR
(n29)
PE With
FGR (n25)
FGR vs
Controls
PE With FGR
vs Controls
FGR
vs PE
Mitral inflow indices
E/A ratio 1.6 (1.2–1.9) 1.4 (1.2–1.6) 1.1 (0.7–1.5) 0.13 0.022 0.03
DT, ms 159 (135–181) 179 (154–208) 210 (192–242) 0.013 0.0001 0.005
IVRT, ms 75 (71–88) 94 (81–99) 88 (74–107) 0.007 0.0001 0.032
Pulmonary venous flow indices
S/D ratio 1.1 (0.9–1.3) 0.9 (0.7–1.2) 1.1 (0.9–1.3) 0.040 0.9 0.04
AR 0.35 m/s 3 (6) 7 (27) 9 (36) 0.023 0.0001 0.5
ARdurAdur 30 ms 1 (2) 3 (12) 10 (40) 0.2 0.0001 0.3
Mitral annular motion indices
Septal E1, cm/s 10 (9–14) 9 (7–12) 8 (6.2–9) 0.01 0.0001 0.001
Lateral E1, cm/s 17 (13–19) 16 (13–17) 11.5 (6.4–11.5) 0.9 0.0001 0.0001
Left heart filling pressure indices
Average E/E1 ratio 5.4 (4.8–6.1) 6.2 (6–6.6) 7.7 (7.4–10.7) 0.011 0.0001 0.0001
E/Vp ratio 0.87 (0.85–1.2) 1.3 (1.1–1.5) 1.5 (1.2–1.7) 0.010 0.0001 0.0001
Strain rate study (8 segment model)
Global early diastole strain rate 2.2 (2.0–2.3) 1.9 (1.3–2.1) 1.6 (0.9–1.8) 0.015 0.0001 0.03
Global early to late diastole strain rate ratio 1.8 (1.5–2.2) 1.6 (1.1–1.8) 1.1 (0.8–1.5) 0.019 0.0001 0.002
Values are given as either median (interquartile) or No. of subjects (percentage). FGR indicates fetal growth restriction; PE, preeclampsia; E, peak early diastole
transmitral wave velocity; A, peak late diastole transmitral wave velocity; E/A, early to late diastole peak transmitral velocity ratio; DT, deceleration time of E wave;
IVRT, isovolumetric relaxation time; S, peak systolic velocity of pulmonary flow; D, peak anterograde early diastolic velocity of pulmonary flow; S/D, S:D ratio; AR,
peak retrograde late diastolic velocity; ARdur, AR duration; (ARdurAdur), the time difference between pulmonary AR duration and mitral A-wave duration; E1, peak
early diastolic velocity at mitral valve annulus; A1, peak late diastolic velocity at the mitral valve annulus; E/E1, E:E1 ratio; Vp, color M-mode propagation flow velocity;
E/Vp, E:Vp ratio.
Table 4. Cardiovascular Changes in Preterm Normotensive FGR, Preterm PE With FGR, and Controls
Parameter
Control
(n58)
FGR
(n29)
PE With
FGR (n25)
FGR vs
Controls
PE With FGR
vs Controls
FGR
vs PE
Hemodynamic
MAP, mm Hg 80 (73–88) 94 (87–98) 118 (115–120) 0.0001 0.0001 0.0001
TVRI, (dynes1cm5)m2 1857 (1553–2005) 2456 (2197–2894) 3622 (3205–4391) 0.0001 0.0001 0.0001
CI, L/min/m2 3.48 (3.09–3.90) 2.73 (2.55–3.26) 2.58 (2.16–2.70) 0.0001 0.0001 0.013
HR 78 (74–87) 67 (60–74) 78 (70–90) 0.0001 0.08 0.004
SVI 40 (38–46) 42 (35–48) 35 (26–46) 0.6 0.001 0.031
Altered geometry 8 (14) 8 (28) 20 (80) 0.2 0.0001 0.0001
Myocardial function
Impaired relaxation 12 (21) 17 (59) 19 (76) 0.0001 0.0001 0.3
Impaired contractility 8 (5) 7 (24) 12 (48) 0.1 0.0001 0.033
Chamber function
Diastolic dysfunction 2 (4) 8 (28) 13 (52) 0.009 0.0001 0.0001
Radial systolic dysfunction 0 1 (4) 7 (28) 0.06 0.0001 0.03
Values are given as median (interquartile range) when indices are provided or as No. (percentage). FGR indicates fetal growth restriction; PE, preeclampsia; MAP,
mean arterial pressure; TVRI, total vascular resistance index; CI, cardiac index; HR, heart rate; SVI, stroke volume index.
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to be important for appropriate utero-placental perfusion and
effective feto-maternal exchange.29,30 Our study demon-
strates that women with FGR pregnancies fail to achieve
these physiological cardiovascular changes and exhibit rela-
tively nonpregnant hemodynamic characteristics (high resis-
tance, low volume, and hypodynamic state) compared with
pregnant controls. The lack of physiological adaptation ap-
pears to be more severe in women with acute preterm PE.
These results on hemodynamics in FGR pregnancies are in
agreement with those from previous studies.13–15 Given the
study design of assessment at disease presentation, it is not
possible to ascertain whether these hemodynamic character-
istics are a cause or effect of the pregnancy pathologies.
However, it would be interesting to hypothesize that, al-
though FGR and PE share common etiologies, the better
cardiovascular reserve evident in women with FGR may
protect them from the development of PE and result in
slightly better long-term cardiovascular outcomes.
Limitations
The sample size was small but adequate to the primary
outcome of the study, which was the detection of diastolic
dysfunction. The exclusion of smokers from the study limits
the ability to evaluate the confounding effect of smoking on
cardiovascular changes and the extrapolation of results to
FGR cases in smoking pregnancies.
Perspectives
Normotensive FGR pregnancy is associated with a failure to
develop a low resistance-high volume circulation, impaired
myocardial relaxation, and asymptomatic diastolic dysfunc-
tion in keeping with PE pregnancy, which shares a common
placental etiology. The finding that women with normoten-
sive FGR pregnancies have preserved systolic function and
unaltered cardiac geometry compared with PE introduces the
concept that better cardiac function in these FGRs may be
important in preventing the development of PE.
The cardiovascular findings seen in FGR pregnancies
are the expression of poor cardiac reserve and may partly explain
the higher risk of cardiovascular disease in these women.
Recent studies of women whose pregnancies were compli-
cated by PE have shown persistence of LV moderate-severe
asymptomatic abnormal function and geometry within 1 to 2
years of delivery in a significant proportion of women.11,12
These findings predispose the latter women to a much higher
risk of hypertension, heart failure, and cardiac death, all of
which may be ameliorated by appropriately timed therapeutic
interventions.31–34 The natural history of asymptomatic dia-
stolic dysfunction in women whose pregnancies were af-
fected by FGR is unknown, and follow-up studies are needed
to assess the latter, as well as the role of interventions, in
preventing cardiovascular morbidity in these women.
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Novelty and Significance
What Is New?
● One third of women with pregnancy complicated by FGR are affected by
asymptomatic global LV diastolic dysfunction with preserved ejection
fraction. Two thirds of them present impaired LV myocardial relaxation.
What Is Relevant?
● The findings of this study have clinical relevance in view of the high
long-term risk of overt heart failure in patients with impaired LV diastolic
function.
Summary
Normotensive FGR pregnancy is associated with a failure to
develop a low resistance-high volume circulation, impaired myo-
cardial relaxation, and asymptomatic global diastolic dysfunction in
keeping with PE pregnancy, which shares a common placental
etiology and common adverse long-term cardiovascular outcome.
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